Correlation Between Zomedica Pharmaceuticals and Cronos
Can any of the company-specific risk be diversified away by investing in both Zomedica Pharmaceuticals and Cronos at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zomedica Pharmaceuticals and Cronos into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zomedica Pharmaceuticals Corp and Cronos Group, you can compare the effects of market volatilities on Zomedica Pharmaceuticals and Cronos and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zomedica Pharmaceuticals with a short position of Cronos. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zomedica Pharmaceuticals and Cronos.
Diversification Opportunities for Zomedica Pharmaceuticals and Cronos
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Zomedica and Cronos is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Zomedica Pharmaceuticals Corp and Cronos Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cronos Group and Zomedica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zomedica Pharmaceuticals Corp are associated (or correlated) with Cronos. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cronos Group has no effect on the direction of Zomedica Pharmaceuticals i.e., Zomedica Pharmaceuticals and Cronos go up and down completely randomly.
Pair Corralation between Zomedica Pharmaceuticals and Cronos
Considering the 90-day investment horizon Zomedica Pharmaceuticals Corp is expected to under-perform the Cronos. In addition to that, Zomedica Pharmaceuticals is 1.53 times more volatile than Cronos Group. It trades about -0.33 of its total potential returns per unit of risk. Cronos Group is currently generating about -0.32 per unit of volatility. If you would invest 217.00 in Cronos Group on September 14, 2024 and sell it today you would lose (25.00) from holding Cronos Group or give up 11.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Zomedica Pharmaceuticals Corp vs. Cronos Group
Performance |
| Timeline |
| Zomedica Pharmaceuticals |
| Cronos Group |
Zomedica Pharmaceuticals and Cronos Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zomedica Pharmaceuticals and Cronos
The main advantage of trading using opposite Zomedica Pharmaceuticals and Cronos positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zomedica Pharmaceuticals position performs unexpectedly, Cronos can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cronos will offset losses from the drop in Cronos' long position.| Zomedica Pharmaceuticals vs. Tilray Inc | Zomedica Pharmaceuticals vs. Aurora Cannabis | Zomedica Pharmaceuticals vs. Canopy Growth Corp | Zomedica Pharmaceuticals vs. OrganiGram Holdings |
| Cronos vs. OrganiGram Holdings | Cronos vs. Aurora Cannabis | Cronos vs. SNDL Inc | Cronos vs. Canopy Growth Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |